1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Partnerships for Indigenous-led ELSI Research (PIER) is sponsored by National Human Genome Research Institute (NIH). This grant supports tribally-led genomic research aimed at addressing American Indian and Alaska Native (AI/AN) health disparities.
The initiative focuses on strengthening meaningful collaboration with AI/AN communities and AI/AN-serving health systems in Alaska and Oklahoma to promote Indigenous-driven approaches to genomic research. It also includes a Community Scholars program to support researchers interested in Tribal health research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Universities, in collaboration with Tribal healthcare organizations and AI/AN communities, are eligible. The project is led by Southcentral Foundation with the University of Oklahoma as a key collaborator. Confirm the full requirements in the official notice before applying.
The current listing shows $1,553,238. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Partnerships for Indigenous-led ELSI Research (PIER) are due June 1, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Partnerships for Indigenous-led ELSI Research (PIER) is funded by National Human Genome Research Institute (NIH). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Oklahoma. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.
Read articleOn November 2, 2026, NIH released NOT-OD-27-006, a draft update to its Policy for Data and Safety Monitoring. As summarized by Harvard's research integrity office, the draft would extend risk-based monitoring from clinical trials to all NIH-supported clinical research, drop the blanket DSMB requirement for Phase 3 and multi-site trials, and require an NIH-approved monitoring plan scaled to risk, effective for applications six months after the final policy. Comments are due January 6, 2027. What it changes and how to respond.
Read articleRFA-EB-28-004, NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18), puts about $6 million into 8 to 12 BRAIN and HEAL Initiative device-development awards. Budgets should rarely exceed $750,000 in direct costs a year, projects run up to three years, nine institutes participate, and there are six due dates from February 1, 2027 through February 1, 2030. Here is what the program requires and how to write a competitive application.
Read article